NBP
NovaBridge Biosciences
NASDAQ · Healthcare · Biotechnology · US
$1.80
+0.00%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-60.2%
Return on equity
-53.4%
Return on assets
-95.0%
Return on invested capital
0.00x
Asset turnover
-$1.4M
Cash from operations
$0.26
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025